Search research articles
Contact Us
Filters
Showing results (1-10 of 65) with videos related to
Page
of 7
Sort By:
Gastroenterology
|
November 7, 2007
Diagnostics of inflammatory bowel disease
Susanna Nikolaus, Stefan Schreiber
Medizinische Monatsschrift Fur Pharmazeuten
|
January 5, 2006
[Genetic factors in longevity. Healthy living into old age--what role do genes play?]
Friederike Flachsbart, Almut Nebel, Susanna Nikolaus, et al.
Gastroenterology
|
May 12, 2018
Reply
Stefan Schreiber, Susanna Nikolaus, Georg H Waetzig, et al.
Gastroenterology
|
August 2, 2003
Differential p38 mitogen-activated protein kinase target phosphorylation in responders and nonresponders to infliximab
Georg H Waetzig, Philip Rosenstiel, Susanna Nikolaus, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 8, 2002
p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease
Georg H Waetzig, Dirk Seegert, Philip Rosenstiel, et al.
BMJ Open Gastroenterology
|
March 1, 2017
Combination therapy with vedolizumab and etanercept in a patient with pouchitis and spondylarthritis
Johannes Bethge, Silvia Meffert, Mark Ellrichmann, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
July 30, 2011
Genetic variation in the CYP2C monooxygenase enzyme subfamily shows no association with longevity in a German population
Friederike Flachsbart, Mike Ufer, Rabea Kleindorp, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 25, 2005
No association between microsomal triglyceride transfer protein (MTP) haplotype and longevity in humans
Almut Nebel, Peter J P Croucher, Rieke Stiegeler, et al.
The American Journal of Gastroenterology
|
October 19, 2002
Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn's disease
Hans Herfarth, Florian Obermeier, Tilo Andus, et al.
European Journal of Human Genetics : EJHG
|
July 30, 2009
Depletion of potential A2M risk haplotype for Alzheimer's disease in long-lived individuals
Friederike Flachsbart, Amke Caliebe, Michael Nothnagel, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 65) with videos related to
Sort By:
Page
of 7
Gastroenterology
|
November 7, 2007
Diagnostics of inflammatory bowel disease
Susanna Nikolaus, Stefan Schreiber
Medizinische Monatsschrift Fur Pharmazeuten
|
January 5, 2006
[Genetic factors in longevity. Healthy living into old age--what role do genes play?]
Friederike Flachsbart, Almut Nebel, Susanna Nikolaus, et al.
Gastroenterology
|
May 12, 2018
Reply
Stefan Schreiber, Susanna Nikolaus, Georg H Waetzig, et al.
Gastroenterology
|
August 2, 2003
Differential p38 mitogen-activated protein kinase target phosphorylation in responders and nonresponders to infliximab
Georg H Waetzig, Philip Rosenstiel, Susanna Nikolaus, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 8, 2002
p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease
Georg H Waetzig, Dirk Seegert, Philip Rosenstiel, et al.
BMJ Open Gastroenterology
|
March 1, 2017
Combination therapy with vedolizumab and etanercept in a patient with pouchitis and spondylarthritis
Johannes Bethge, Silvia Meffert, Mark Ellrichmann, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
July 30, 2011
Genetic variation in the CYP2C monooxygenase enzyme subfamily shows no association with longevity in a German population
Friederike Flachsbart, Mike Ufer, Rabea Kleindorp, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 25, 2005
No association between microsomal triglyceride transfer protein (MTP) haplotype and longevity in humans
Almut Nebel, Peter J P Croucher, Rieke Stiegeler, et al.
The American Journal of Gastroenterology
|
October 19, 2002
Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn's disease
Hans Herfarth, Florian Obermeier, Tilo Andus, et al.
European Journal of Human Genetics : EJHG
|
July 30, 2009
Depletion of potential A2M risk haplotype for Alzheimer's disease in long-lived individuals
Friederike Flachsbart, Amke Caliebe, Michael Nothnagel, et al.
Page
of 7